(Q35827325)

10 August 2017

Effect of rifampicin on the pharmacokinetics of pioglitazone (English)

1 reference

10 August 2017

1 reference

1 reference

Mikko Neuvonen

3

0 references

Janne Backman

object named as

Janne T Backman

2

0 references

Pertti J. Neuvonen

object named as

Pertti J Neuvonen

5

0 references

author name string

Tiina Jaakkola

1

1 reference

10 August 2017

Jouko Laitila

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

61

1 reference

10 August 2017

1

1 reference

10 August 2017

70-78

1 reference

Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicin

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Pharmacokinetic interactions with rifampicin : clinical relevance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Pioglitazone: a review of Japanese clinical studies.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Pharmacokinetics and clinical efficacy of pioglitazone.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Induction of CYP2C genes in human hepatocytes in primary culture

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Rifampin decreases the plasma concentrations and effects of repaglinide

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone

11 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02515.X

Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02515.X

Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02515.X

Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02515.X

Identification of novel metabolites of pioglitazone in rat and dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02515.X

Effect of fluconazole on the pharmacokinetics and pharmacodynamics of nateglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02515.X

Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02515.X

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884976

Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations

24 September 2018

1 reference

12 December 2020

The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism

1 reference

12 December 2020

Triazolam is ineffective in patients taking rifampin

1 reference

12 December 2020

Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin

1 reference

12 December 2020

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

1 reference

12 December 2020

10.1111/J.1365-2125.2005.02515.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

16390353

1 reference